middle.news
EVE Health Group launches Libbo and Dyspro with expanded $30B pipeline
5:22pm on Monday 31st of August, 2026 AEST
•
Healthcare
Read Story
EVE Health Group launches Libbo and Dyspro with expanded $30B pipeline
5:22pm on Monday 31st of August, 2026 AEST
Key Points
Commercial launch of Libbo® and Dyspro® under Special Access Scheme
Pilot bioequivalence study initiated for Libbo®
Expanded reformulation pipeline targeting sexual health and anticoagulants
Raised $2.4 million through placements including cornerstone investor
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Eve Health (ASX:EVE)
OPEN ARTICLE